Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
budesonide (rhinocort) (2021)
Key: Calliditas Therapeutics (1) Acquired (1)
budesonide (rhinocort) (4 trials)
setanaxib (2 trials)
Key: Calliditas Therapeutics (0) Acquired (2)
gkt137831 (3 trials)
procervix (1 trial)
Key: Calliditas Therapeutics (1) Acquired (2)
greenshell mussel extract (1 trial)
gtl001 (1 trial)
imiquimod (aldara) (1 trial)
fish oil (Omegavan) (1 trial)
immune globulin (human) (Gamastan) (1 trial)
Glomerulonephritis, IGA (Phase 3)
Kidney Diseases (Phase 3)
Kidney Failure, Chronic (Phase 2)
Trials (14 total)
Trial APIs (9 total)